Here, professionals and patients will find short summaries (“abstracts”) of scientific publications concerning the agents used in our products. If available, a link to the online-version of the publication will be given.
Study design: Long term prospective non-randomised trial to compare therapeutic effectiveness of corticosteroids (CS) and CS plus D-penicillamine (D-pen) in patients with … » More
Study design: D-penicillamine (D-pen) was tested on mouse artoa rings for its vasodilatory effect as a possible cysteine analogue and its effect on H2S … » More
Study design: This report surveys the case of a female patient presenting weakness of the limbs, malaise, fatigue, atypical chest pain and palpitation due to mercury … » More
Study design: This study compared several neonatal parameters of babies born by mothers with critical level of mercury in their blood who were either treated (group 1) with … » More
Study Design: Wistar rats received 0 mg/kg, 11.6 mg/kg, 23.2 mg/kg or 32.4 mg/kg hexacyanoferrate (II) potassium-ferric (III) orally for 30 days to compare influence on … » More
Study Design: Prussian Blue (PB) nanoparticles in various forms were compared for their ability to adsorb cesium (Cs) from water. Results: Water dispersible nano-PB could … » More
Study Design: Dogs received D-penicillamine (12.5 mg/kg PO) fasted and with food in a randomized, crossover design to test the effect if food on the … » More